[Treatment of endometriosis in female infertility].

article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-13

Duphaston treatment for six months led to regression of endometriosis foci in 13 of 16 infertile women, with 56.7% achieving pregnancy afterward.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A total of 16 women with endometriosis 25 to 36 years old were examined. Of these, 6 presented with primary infertility, 10--with secondary intertility, 7 female patients had endometriosis concurrent with other localizations. The treatment was with duphaston (dydrogesteron), 10 mg (5 mg twice a day) beginning from day 5 till 25 of the menstrual cycle for 6 months. The control echography and hysteroscopy permitted ascertaining regression of endometrioid foci in 13 female patients. According to the histological findings in 15 women the endometrium corresponded to the proliferative phase of the menstrual cycle, with its focal hyperplasia having been noted in 1 woman. Efficacy of treatment aimed to return the reproductive function back to normal was assessed in 14 female patients. The pregnancy incidence after the treatment came up to 56.7% (9 women). Thus, duphaston is an effective drug that can be recommended for treating endometriosis in those women at reproductive age presenting with infertility.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Infertility, Female Adult CA-125 Antigen CA-125 Antigen Dydrogesterone Dydrogesterone Dydrogesterone Endometriosis Endometriosis Endometriosis Female Humans Hysterosalpingography Hysteroscopy Infertility, Female Infertility, Female Laparoscopy Pregnancy Progesterone Congeners

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (4)

Cited by (4)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:19.284922+00:00
License: CC0 · commercial use OK